Literature DB >> 7561961

Spongy degeneration in the zitter rat: ultrastructural and immunohistochemical studies.

A Kondo1, S Sendoh, K Miyata, J Takamatsu.   

Abstract

Pathological changes in the grey matter of the zitter rat were examined by electron microscopy and immunohistochemistry to investigate the pathogenesis of spongy degeneration. Vacuole formation was first detected in the pons and the outer thalamus at 2 weeks of age. The vacuoles arose from the periaxonal or inter-myelinic spaces as well as the cytoplasm of some oligodendrocytes or astrocytes. With increasing age, some dendrites and the cytoplasm of neurons developed an electron lucent area with sparse organelles and the vacuoles occasionally fused together. Although spongy degeneration gradually extended to the entire CNS, no inflammatory or phagocytotic cell infiltration and no viral particles were detected. Glial fibrillary acidic protein immunoreactivity increased transiently in the vacuolated areas from 2 to 15 weeks of age (maximal at 7 weeks of age). Although zitter rats older than 65 weeks showed some reactive astrocytes in vacuolated areas, their numbers and the intensity of immunostaining decreased with advanced vacuolation suggesting astrocytic hypofunction in response to tissue damage. Immunoreactivity for synaptophysin was weaker in the zitter rats than in the control rats throughout the observation period, which suggested that synapse formation was disturbed in the zitter rats, probably due to a combination of hypomyelination and vacuole formation in the grey matter. These findings suggest that an unknown genetic abnormality, probably related to cell membrane biosynthesis or cell-to-cell interactions, produces both hypomyelination and spongy degeneration in the zitter rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561961     DOI: 10.1007/BF01179978

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  8 in total

1.  A rat mutation producing demyelination (dmy) maps to chromosome 17.

Authors:  T Kuramoto; C Sotelo; N Yokoi; T Serikawa; E Goñalons Sintes; J Cantó Martorell; J L Guénet
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

2.  Attractin/mahogany/zitter plays a critical role in myelination of the central nervous system.

Authors:  T Kuramoto; K Kitada; T Inui; Y Sasaki; K Ito; T Hase; S Kawagachi; Y Ogawa; K Nakao; G S Barsh; M Nagao; T Ushijima; T Serikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination.

Authors:  C Neusch; N Rozengurt; R E Jacobs; H A Lester; P Kofuji
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

4.  Hypomyelinating leukodystrophy associated with a deleterious mutation in the ATRN gene.

Authors:  Maher Awni Shahrour; Motee Ashhab; Simon Edvardson; Michal Gur; Bassam Abu-Libdeh; Orly Elpeleg
Journal:  Neurogenetics       Date:  2017-05-10       Impact factor: 2.660

5.  Molecular and phenotypic analysis of Attractin mutant mice.

Authors:  T M Gunn; T Inui; K Kitada; S Ito; K Wakamatsu; L He; D M Bouley; T Serikawa; G S Barsh
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

6.  Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences.

Authors:  Ayuka Ehara; Shuichi Ueda
Journal:  Acta Histochem Cytochem       Date:  2009-12-22       Impact factor: 1.938

Review 7.  The ubiquitin-proteasome system in spongiform degenerative disorders.

Authors:  Brandi R Whatley; Lian Li; Lih-Shen Chin
Journal:  Biochim Biophys Acta       Date:  2008-08-23

8.  Minocycline Alleviates Cluster Formation of Activated Microglia and Age-dependent Dopaminergic Cell Death in the Substantia Nigra of Zitter Mutant Rat.

Authors:  Daisuke Taguchi; Ayuka Ehara; Taro Kadowaki; Shin-Ichi Sakakibara; Kazuhiko Nakadate; Koichi Hirata; Shuichi Ueda
Journal:  Acta Histochem Cytochem       Date:  2020-11-21       Impact factor: 1.938

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.